These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 2441416

  • 21. [Fetal hemoglobin].
    Rokicka-Piotrowicz M.
    Postepy Hig Med Dosw; 1989; 43(5-6):475-97. PubMed ID: 2484927
    [Abstract] [Full Text] [Related]

  • 22. Decreased plasma endothelin-1 levels in children with sickle cell disease treated with hydroxyurea.
    Lapouméroulie C, Benkerrou M, Odièvre MH, Ducrocq R, Brun M, Elion J.
    Haematologica; 2005 Mar; 90(3):401-3. PubMed ID: 15749673
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hydroxyurea in sickle cell disease.
    Schechter AN, Rodgers GP.
    N Engl J Med; 1996 Feb 01; 334(5):333. PubMed ID: 8532042
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.
    Coleman E, Inusa B.
    Clin Pediatr (Phila); 2007 Jun 01; 46(5):386-91. PubMed ID: 17556734
    [Abstract] [Full Text] [Related]

  • 28. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
    Yang YM, Pace B.
    Pediatr Pathol Mol Med; 2001 Jun 01; 20(1):87-106. PubMed ID: 12673846
    [Abstract] [Full Text] [Related]

  • 29. Modulation of erythroid adhesion receptor expression by hydroxyurea in children with sickle cell disease.
    Odièvre MH, Bony V, Benkerrou M, Lapouméroulie C, Alberti C, Ducrocq R, Jacqz-Aigrain E, Elion J, Cartron JP.
    Haematologica; 2008 Apr 01; 93(4):502-10. PubMed ID: 18322255
    [Abstract] [Full Text] [Related]

  • 30. Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease.
    Saunthararajah Y, Hillery CA, Lavelle D, Molokie R, Dorn L, Bressler L, Gavazova S, Chen YH, Hoffman R, DeSimone J.
    Blood; 2003 Dec 01; 102(12):3865-70. PubMed ID: 12907443
    [Abstract] [Full Text] [Related]

  • 31. [Effect of hydroxyurea on hemoglobin S].
    Torres AF, Eberle SE, Sciuccati G, Bonduel M.
    Medicina (B Aires); 2003 Dec 01; 63(2):140-2. PubMed ID: 12793083
    [Abstract] [Full Text] [Related]

  • 32. Stimulation of fetal hemoglobin production by hydroxyurea in sickle cell anemia.
    Dover GJ, Charache S.
    Prog Clin Biol Res; 1989 Dec 01; 316B():295-306. PubMed ID: 2482499
    [No Abstract] [Full Text] [Related]

  • 33. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
    Conran N, Fattori A, Saad ST, Costa FF.
    Am J Hematol; 2004 Aug 01; 76(4):343-7. PubMed ID: 15282666
    [Abstract] [Full Text] [Related]

  • 34. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H, Sutton M, Atweh GF.
    Ann N Y Acad Sci; 2005 Aug 01; 1054():228-37. PubMed ID: 16339670
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Determinants of vaso-occlusive severity in sickle cell disease.
    Steinberg MH.
    Prog Clin Biol Res; 1987 Aug 01; 240():413-28. PubMed ID: 3303060
    [No Abstract] [Full Text] [Related]

  • 37. Minireview: Prognostic factors and the response to hydroxurea treatment in sickle cell disease.
    Wang WC.
    Exp Biol Med (Maywood); 2016 Apr 01; 241(7):730-6. PubMed ID: 27026724
    [Abstract] [Full Text] [Related]

  • 38. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP.
    Semin Hematol; 1997 Jul 01; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [Abstract] [Full Text] [Related]

  • 39. The effects of variable doses of 5-azacytidine on fetal hemoglobin production in sickle cell anemia.
    Dover GJ, Charache SH.
    Prog Clin Biol Res; 1984 Jul 01; 165():73-83. PubMed ID: 6209731
    [No Abstract] [Full Text] [Related]

  • 40. The role of fluctuating populations of blood cells in the acute painful episodes of sickle cell disease.
    Embury SH.
    Prog Clin Biol Res; 1987 Jul 01; 240():287-96. PubMed ID: 3615493
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.